BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26802139)

  • 1. Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.
    Bruce MG; Bruden D; Hurlburt D; Zanis C; Thompson G; Rea L; Toomey M; Townshend-Bulson L; Rudolph K; Bulkow L; Spradling PR; Baum R; Hennessy T; McMahon BJ
    J Infect Dis; 2016 Jul; 214(1):16-22. PubMed ID: 26802139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.
    McMahon BJ; Dentinger CM; Bruden D; Zanis C; Peters H; Hurlburt D; Bulkow L; Fiore AE; Bell BP; Hennessy TW
    J Infect Dis; 2009 Nov; 200(9):1390-6. PubMed ID: 19785526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose.
    Bruce MG; Bruden D; Hurlburt D; Morris J; Bressler S; Thompson G; Lecy D; Rudolph K; Bulkow L; Hennessy T; Simons BC; Weng MK; Nelson N; McMahon BJ
    Hepatology; 2022 Oct; 76(4):1180-1189. PubMed ID: 35320592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus antibody levels 7 to 9 years after booster vaccination in Alaska native persons.
    Keck JW; Bulkow LR; Raczniak GA; Negus SE; Zanis CL; Bruce MG; Spradling PR; Teshale EH; McMahon BJ
    Clin Vaccine Immunol; 2014 Sep; 21(9):1339-42. PubMed ID: 25056363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
    Zanetti AR; Romanò L; Giambi C; Pavan A; Carnelli V; Baitelli G; Malchiodi G; Valerio E; Barale A; Marchisio MA; Montù D; Tozzi AE; D'Ancona F;
    Lancet Infect Dis; 2010 Nov; 10(11):755-61. PubMed ID: 20884297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers.
    Williams JL; Christensen CJ; McMahon BJ; Bulkow LR; Cagle HH; Mayers JS; Zanis CL; Parkinson AJ; Margolis HS
    Vaccine; 2001 Jul; 19(28-29):4081-5. PubMed ID: 11427285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N; Abdalla A; Rivera E; Zhao X; Werner JM; Liang TJ; Hoofnagle JH; Rehermann B; Ghany MG
    Clin Infect Dis; 2015 Feb; 60(4):505-13. PubMed ID: 25389254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to booster doses of hepatitis B vaccine among young adults who had received neonatal vaccination.
    Chan PK; Ngai KL; Lao TT; Wong MC; Cheung T; Yeung AC; Chan MC; Luk SW
    PLoS One; 2014; 9(9):e107163. PubMed ID: 25198289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.
    Giambi C; Bella A; Barale A; Montù D; Marchisio M; Oddone M; Zito S; Rapicetta M; Chionne P; Madonna E; Ciofi degli Atti ML
    BMC Infect Dis; 2008 Jul; 8():100. PubMed ID: 18662386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth.
    Petersen KM; Bulkow LR; McMahon BJ; Zanis C; Getty M; Peters H; Parkinson AJ
    Pediatr Infect Dis J; 2004 Jul; 23(7):650-5. PubMed ID: 15247604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.
    Dentinger CM; McMahon BJ; Butler JC; Dunaway CE; Zanis CL; Bulkow LR; Bruden DL; Nainan OV; Khristova ML; Hennessy TW; Parkinson AJ
    Pediatr Infect Dis J; 2005 Sep; 24(9):786-92. PubMed ID: 16148845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
    Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
    Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.